Greece vs Slovenia: The number of people with susceptibility test result for rifampicin
Greece
55
in 2021
Slovenia
58
in 2021
Greece rank
121st
Slovenia rank
119th
The number of people with susceptibility test result for rifampicin over time
- Greece
- Slovenia
How they compare
Slovenia currently reports 58 against 55 in Greece, a difference of 3.
That makes Slovenia's figure about 1.1 times Greece's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Greece ahead.
Greece ranks 121st and Slovenia ranks 119th of 155 countries.
Greece has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Greece | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 149.33 | 77.67 | 71.67 | Greece |
| 2020s | 159 | 57.5 | 101.5 | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Greece or Slovenia?
- Slovenia, at 58 against 55 in Greece as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Greece and Slovenia?
- 3, with Slovenia ahead.
- How many years of comparable data are there for Greece and Slovenia?
- 5 years are reported by both, from 2017 to 2021.
- How do Greece and Slovenia rank globally for the number of people with susceptibility test result for rifampicin?
- Greece ranks 121st and Slovenia ranks 119th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.